Leiden University Medical Center or LUMC is the university hospital affiliated with Leiden University, of which it forms the medical faculty. It is located in Leiden, Netherlands. LUMC is a modern university medical center for research, education and patient care.

During the past decade, Department of Clinical Oncology, Leiden University Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Clinical Oncology, Leiden University Medical Center" #1 collaborator was "European Commission" with 2 trials as a collaborator, "Oxford University Hospitals NHS Trust" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "Millennium: The Takeda Oncology Company" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Department of Clinical Oncology, Leiden University Medical Center" are "Malignant Melanoma" (1 trials), "Osteosarcoma" (1 trials), "Ovarian Cancer" (1 trials), "Refractory Ewing Sarcoma" (1 trials) and "Relapsed Ewing Sarcoma" (1 trials). Many other conditions were trialed in "Department of Clinical Oncology, Leiden University Medical Center" in a lesser frequency.

Most popular intervention types in "Department of Clinical Oncology, Leiden University Medical Center" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine (Chemotherapy)" (1 trials), "Ifosfamide" (1 trials), "Linsitinib" (1 trials), "Mifamurtide" (1 trials) and "Paclitaxel (Chemotherapy)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Clinical Oncology, Leiden University Medical Center" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Department of Clinical Oncology, Leiden University Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Department of Clinical Oncology, Leiden University Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Clinical Oncology, Leiden University Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".